Optimization of contrast enhancement in thoracic MDCT.
Bae KT.
Radiol Clin North Am. 2010 Jan;48(1):9-29. doi: 10.1016/j.rcl.2009.08.012.
Nanotechnology and MRI contrast enhancement.
Matson ML, Wilson LJ.
Future Med Chem. 2010 Mar;2(3):491-502. doi: 10.4155/fmc.10.3.
Analysis of contrast time-enhancement curves to optimise CT pulmonary angiography.
Zhu J, Wang Z, Kim Y, Bae SK, Tao C, Gong J, Bae KT.
Clin Radiol. 2017 Apr;72(4):340.e9-340.e16. doi: 10.1016/j.crad.2016.11.018. Epub 2016 Dec 24.
Contrast enhancement in magnetic resonance imaging using intravenous paramagnetic contrast media: a review.
Kuriashkin IV, Losonsky JM.
Vet Radiol Ultrasound. 2000 Jan-Feb;41(1):4-7. doi: 10.1111/j.1740-8261.2000.tb00419.x.
Advances in contrast enhancement for optical coherence tomography.
Boppart SA.
Conf Proc IEEE Eng Med Biol Soc. 2006;2006:121-4. doi: 10.1109/IEMBS.2006.259366.
Quantitative Assessment of Contrast Enhancement on Contrast Enhancement Spectral Mammography (CESM) and Comparison With Qualitative Assessment.
Rudnicki W, Heinze S, Popiela T, Kojs Z, Luczynska E.
Anticancer Res. 2020 May;40(5):2925-2932. doi: 10.21873/anticanres.14270.
Multi-slice CT contrast enhancement regimens.
Dawson P.
Clin Radiol. 2004 Dec;59(12):1051-60. doi: 10.1016/j.crad.2004.07.009.
Cyclen-based Gd(3+) complexes as MRI contrast agents: Relaxivity enhancement and ligand design.
Rashid HU, Martines MAU, Jorge J, de Moraes PM, Umar MN, Khan K, Rehman HU.
Bioorg Med Chem. 2016 Nov 15;24(22):5663-5684. doi: 10.1016/j.bmc.2016.09.069. Epub 2016 Oct 1.
MR contrast enhancement of intracranial lesions with Gd-DTPA.
Hesselink JR, Press GA.
Radiol Clin North Am. 1988 Jul;26(4):873-87.
Contrast-enhancement influences skeletal muscle density, but not skeletal muscle mass, measurements on computed tomography.
van Vugt JLA, Coebergh van den Braak RRJ, Schippers HJW, Veen KM, Levolger S, de Bruin RWF, Koek M, Niessen WJ, IJzermans JNM, Willemsen FEJA.
Clin Nutr. 2018 Oct;37(5):1707-1714. doi: 10.1016/j.clnu.2017.07.007. Epub 2017 Jul 14.
